Research Analysts’ Recent Ratings Changes for Centene (CNC)

A number of firms have modified their ratings and price targets on shares of Centene (NYSE: CNC) recently:

• 12/17/2024 – Centene had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $80.00.
• 12/13/2024 – Centene had its price target raised by analysts at Barclays PLC from $91.00 to $93.00. They now have an “overweight” rating on the stock.
• 12/13/2024 – Centene had its price target lowered by analysts at Oppenheimer Holdings Inc. from $95.00 to $85.00. They now have an “outperform” rating on the stock.
• 12/13/2024 – Centene had its price target lowered by analysts at Stephens from $75.00 to $73.00. They now have an “equal weight” rating on the stock.
• 12/13/2024 – Centene had its price target lowered by analysts at Truist Financial Co. from $89.00 to $84.00. They now have a “buy” rating on the stock.
• 12/13/2024 – Centene was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating. They now have a $80.00 price target on the stock, up previously from $79.00.
• 12/11/2024 – Centene had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $90.00 price target on the stock.
• 12/10/2024 – Centene was downgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to an “underperform” rating. They now have a $52.00 price target on the stock, down previously from $68.00.
• 11/4/2024 – Centene had its price target lowered by analysts at Wells Fargo & Company from $91.00 to $90.00. They now have an “overweight” rating on the stock.
• 10/30/2024 – Centene had its price target lowered by analysts at Sanford C. Bernstein from $96.00 to $88.00. They now have an “outperform” rating on the stock.
• 10/29/2024 – Centene had its price target lowered by analysts at Barclays PLC from $97.00 to $91.00. They now have an “overweight” rating on the stock.
• 10/28/2024 – Centene was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating.

Centene Stock Performance

NYSE CNC opened at $60.83 on Wednesday. The company has a market capitalization of $30.71 billion, a price-to-earnings ratio of 10.56, a PEG ratio of 0.78 and a beta of 0.46. Centene Co. has a twelve month low of $55.03 and a twelve month high of $81.42. The stock has a fifty day simple moving average of $60.50 and a 200 day simple moving average of $68.12. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64.

Insider Transactions at Centene

In related news, CEO Sarah London acquired 4,117 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were bought at an average price of $60.80 per share, with a total value of $250,313.60. Following the transaction, the chief executive officer now directly owns 667,229 shares of the company’s stock, valued at $40,567,523.20. This trade represents a 0.62 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Thomas Greco acquired 17,000 shares of the firm’s stock in a transaction dated Wednesday, December 18th. The shares were purchased at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the acquisition, the director now owns 19,309 shares of the company’s stock, valued at approximately $1,153,712.75. This represents a 736.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 45,010 shares of company stock worth $2,660,276. Company insiders own 0.33% of the company’s stock.

Institutional Trading of Centene

Several institutional investors and hedge funds have recently modified their holdings of CNC. Vantage Investment Partners LLC lifted its holdings in Centene by 17.1% during the third quarter. Vantage Investment Partners LLC now owns 683,817 shares of the company’s stock worth $51,478,000 after acquiring an additional 99,904 shares during the period. State Street Corp boosted its stake in Centene by 0.5% in the third quarter. State Street Corp now owns 23,468,159 shares of the company’s stock valued at $1,766,683,000 after acquiring an additional 111,654 shares during the last quarter. Daiwa Securities Group Inc. increased its stake in shares of Centene by 31.1% during the 3rd quarter. Daiwa Securities Group Inc. now owns 118,810 shares of the company’s stock worth $8,944,000 after purchasing an additional 28,175 shares during the last quarter. National Pension Service lifted its stake in Centene by 15.4% in the third quarter. National Pension Service now owns 1,435,482 shares of the company’s stock valued at $108,063,000 after purchasing an additional 191,768 shares during the last quarter. Finally, Investment Management Corp of Ontario raised its stake in shares of Centene by 273.5% in the third quarter. Investment Management Corp of Ontario now owns 44,285 shares of the company’s stock valued at $3,334,000 after buying an additional 32,428 shares during the period. 93.63% of the stock is owned by hedge funds and other institutional investors.

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.